Biblio

Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Ling, X., Wu, W., Fan, C., Xu, C., Liao, J., Rich, L.J., Huang, R.-Y., Repasky, E.A., Wang, X., and Li, F. (2018). An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer.J Exp Clin Cancer Res37, 240.
Mato, E., Gonzalez, C., Moral, A., Pérez, J.Ignacio, Bell, O., Lerma, E., and de Leiva, A. (2014). ABCG2/BCRP gene expression related with EMT inducer genes in papillary thyroid carcinoma.J Mol Endocrinol.
Marriott, S., Baskir, R.S., Gaskill, C., Menon, S., Carrier, E.J., Williams, J., Talati, M., Helm, K., Alford, C.E., Kropski, J.A., et al. (2014). ABCG2pos Lung Mesenchymal Stem Cells are a Novel Pericyte Subpopulation that Contributes to Fibrotic Remodeling.Am J Physiol Cell Physiol.
Czornyj, L., and Lazarowski, A. (2014). ABC-transporters as stem-cell markers in brain dysplasia/tumor epilepsies.Front Biosci (Landmark Ed)19, 1425-1435.
Chen, S., Yi, M., Zhou, G., Pu, Y., Hu, Y., Han, M., and Jin, H. (2019). Abdominal Aortic Transplantation of Bone Marrow Mesenchymal Stem Cells Regulates the Expression of Ciliary Neurotrophic Factor and Inflammatory Cytokines in a Rat Model of Spinal Cord Ischemia-Reperfusion Injury.Med Sci Monit25, 1960-1969.
Murphy, A.J., Pierce, J., de Caestecker, C., Libes, J., Neblett, D., de Caestecker, M., Perantoni, A.O., Tanigawa, S., Anderson, J.R., Dome, J.S., et al. (2013). Aberrant activation, nuclear localization, and phosphorylation of yes-associated protein-1 in the embryonic kidney and Wilms tumor.Pediatr Blood Cancer.
Lindblad, O., Cordero, E., Puissant, A., Macaulay, L., Ramos, A., Kabir, N.N., Sun, J., Vallon-Christersson, J., Haraldsson, K., Hemann, M.T., et al. (2016). Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML.Oncogene.
Mizuno, G.O., Wang, Y., Shi, G., Wang, Y., Sun, J., Papadopoulos, S., Broussard, G.J., Unger, E.K., Deng, W., Weick, J., et al. (2018). Aberrant Calcium Signaling in Astrocytes Inhibits Neuronal Excitability in a Human Down Syndrome Stem Cell Model.Cell Rep24, 355-365.
Kawano, H., Ito, Y., Kanai, F., Nakamura, E., Tada, N., Takai, S., Horie, S., Kobayashi, T., and Hino, O. (2015). Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway.Oncol Rep.
Sriraksa, R., Zeller, C., Dai, W., Siddiq, A., Walley, A.J., Limpaiboon, T., and Brown, R. (2013). Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumours.Cancer Prev Res (Phila).
Sakaguchi, H., Muramatsu, H., Okuno, Y., Makishima, H., Xu, Y., Furukawa-Hibi, Y., Wang, X., Narita, A., Yoshida, K., Shiraishi, Y., et al. (2015). Aberrant DNA Methylation Is Associated with a Poor Outcome in Juvenile Myelomonocytic Leukemia.Plos One10, e0145394.
Tesarova, L., Simara, P., Stejskal, S., and Koutna, I. (2016). The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.Plos One11, e0157974.
Planello, A.C., Ji, J., Sharma, V., Singhania, R., Mbabaali, F., Müller, F., Alfaro, J.A., Bock, C., De Carvalho, D.D., and Batada, N.N. (2014). Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors.Cell Regen (Lond)3, 4.
Xiong, L., Wu, F., Wu, Q., Xu, L., Cheung, O.K., Kang, W., Mok, M.T., Szeto, L.L.M., Lun, C.-Y., Lung, R.W., et al. (2019). Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.Nat Commun10, 335.
Davis, H., Irshad, S., Bansal, M., Rafferty, H., Boitsova, T., Bardella, C., Jaeger, E., Lewis, A., Freeman-Mills, L., Giner, F.C., et al. (2014). Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche.Nat Med.
Forget, A., Martignetti, L., Puget, S., Calzone, L., Brabetz, S., Picard, D., Montagud, A., Liva, S., Sta, A., Dingli, F., et al. (2018). Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.Cancer Cell34, 379-395.e7.
Raeisossadati, R., Abbaszadegan, M.Reza, Moghbeli, M., Tavassoli, A., Kihara, A.Hiroaki, and Forghanifard, M.Mahdi (2014). Aberrant expression of DPPA2 and HIWI genes in colorectal cancer and their impacts on poor prognosis.Tumour Biol.
Indu, S., Sekhar, S.C., Sengottaiyan, J., Kumar, A., Pillai, S.M., Laloraya, M., and Kumar, P.G. (2015). Aberrant expression of Dynein light chain 1 is associated with human male factor infertility.Mol Cell Proteomics.
Ponandai-Srinivasan, S., Andersson, K.L., Nistér, M., Saare, M., Hassan, H.A., Varghese, S.J., Peters, M., Salumets, A., Gemzell-Danielsson, K., and Lalitkumar, P.Grace Luth (2018). Aberrant expression of genes associated with stemness and cancer in endometria and endometrioma in a subset of women with endometriosis.Hum Reprod.
Hua, M., Li, J., Wang, C., Shao, L., Hou, M., Peng, J., and Feng, Q. (2019). Aberrant expression of microRNA in CD4 cells contributes to Th17/Treg imbalance in primary immune thrombocytopenia.Thromb Res177, 70-78.
Qiao, J., Liu, Y., Wu, Y., Li, X., Zhu, F., Xia, Y., Yao, H., Chu, P., Li, H., Ma, P., et al. (2015). Aberrant expression of RUNX3 in patients with immune thrombocytopenia.Int Immunopharmacol.
Sakao-Suzuki, M., Kawasaki, H., Akamatsu, T., Meguro, S., Miyajima, H., Iwashita, T., Tsutsui, Y., Inoue, N., and Kosugi, I. (2014). Aberrant fetal macrophage/microglial reactions to cytomegalovirus infection.Ann Clin Transl Neurol1, 570-88.
Paduch, D.A., Hilz, S., Grimson, A., Schlegel, P.N., Jedlicka, A.E., and Wright, W.W. (2019). Aberrant gene expression by Sertoli cells in infertile men with Sertoli cell-only syndrome.Plos One14, e0216586.
Massolt, E.T., Effraimidis, G., Korevaar, T.I.M., Wiersinga, W.M., W Visser, E., Peeters, R.P., and Drexhage, H.A. (2016). Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease.Plos One11, e0153892.
Visweswaran, M., Arfuso, F., Warrier, S., and Dharmarajan, A. (2019). Aberrant lipid metabolism as an emerging therapeutic strategy to target cancer stem cells: Concise review.Stem Cells.

Pages